Company profile FRTX

Fresh Tracks Therapeutics Inc
brickell biotech, inc. is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated therapeutics for the treatment of skin diseases. our management team and board of directors has extensive experience in product development, having served in leadership roles at several pharmaceutical and successful start-up companies. our strategy is to... leverage this experience to in-license, acquire, develop and commercialize products that we believe can be successful in the global dermatology marketplace. our portfolio of five product candidates, all new molecular entities with relevant mechanism of actions in skin diseases, targets significant market opportunities. Show More
Quarter analysis & expected interestLast update: February 07 2024 23:55:09.

After 38 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 53 days it will total up to 0.0.
Fresh Tracks Therapeutics expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
2019107
111
3.7% QoQ
128
15.3% QoQ
136
6.2% QoQ
2020 64
-40.2% YoY -52.9% QoQ
160
44.1% YoY 150.0% QoQ
16
-87.5% YoY -90.0% QoQ
82
-39.7% YoY 412.5% QoQ
2021 0
-100.0% YoY -100.0% QoQ
99
-38.1% YoY inf% QoQ
193
1106.2% YoY 94.9% QoQ
267
225.6% YoY 38.3% QoQ
2022 16
inf% YoY -94.0% QoQ
40
-59.6% YoY 150.0% QoQ
97
-49.7% YoY 142.5% QoQ
223
-16.5% YoY 129.9% QoQ
2023 94
487.5% YoY -57.8% QoQ
21
-47.5% YoY -77.7% QoQ
170
75.3% YoY 709.5% QoQ
92
-58.7% YoY -45.9% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Fresh Tracks Therapeutics search interestLast update: February 07 2024 23:55:08.
Correlation coefficient between keyword and revenue is 0.93
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 07 2024 23:55:10.

The average 5 years interest of Fresh Tracks Therapeutics was 8.14 per week.
The last year interest of Fresh Tracks Therapeutics compared to the last 5 years has changed by -21.74%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -34.93%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for FRTX-02 to provide analysis

Correlation between past revenue and FRTX-02 search interest

There is not enough data for FRTX-02 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for FRTX-02 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: October 23 2023 04:13:19.

After 15 days of this quarter the interest is at 68.0. Based on that we can calculate that during remaining 77 days it will total up to 417.0.
autoimmune diseases treatment expected interest is significantly higher compared to same quarter last year (+127.9%) but similar to previous quarter.

YearQ1Q2Q3Q4
2018 - - - 228
2019 244
7.0% QoQ
346
41.8% QoQ
327
-5.5% QoQ
314
37.7% YoY -4.0% QoQ
2020 378
54.9% YoY 20.4% QoQ
262
-24.3% YoY -30.7% QoQ
245
-25.1% YoY -6.5% QoQ
229
-27.1% YoY -6.5% QoQ
2021 227
-39.9% YoY -0.9% QoQ
233
-11.1% YoY 2.6% QoQ
79
-67.8% YoY -66.1% QoQ
168
-26.6% YoY 112.7% QoQ
2022 283
24.7% YoY 68.5% QoQ
379
62.7% YoY 33.9% QoQ
180
127.8% YoY -52.5% QoQ
183
8.9% YoY 1.7% QoQ
2023 299
5.7% YoY 63.4% QoQ
344
-9.2% YoY 15.1% QoQ
319
77.2% YoY -7.3% QoQ
68
-62.8% YoY -78.7% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and autoimmune diseases treatment search interestLast update: October 23 2023 04:13:19.
Correlation coefficient between keyword and revenue is 0.28
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: October 23 2023 04:13:19.

The average 5 years interest of autoimmune diseases treatment was 20.52 per week.
The last year interest of autoimmune diseases treatment compared to the last 5 years has changed by 8.33%.
The interest for autoimmune diseases treatment is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by -10.18%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for inflammatory diseases treatment to provide analysis

Correlation between past revenue and inflammatory diseases treatment search interest

There is not enough data for inflammatory diseases treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for inflammatory diseases treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for FRTX-10 to provide analysis

Correlation between past revenue and FRTX-10 search interest

There is not enough data for FRTX-10 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for FRTX-10 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for rare genetic diseases treatment to provide analysis

Correlation between past revenue and rare genetic diseases treatment search interest

There is not enough data for rare genetic diseases treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for rare genetic diseases treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for FRTX-03 to provide analysis

Correlation between past revenue and FRTX-03 search interest

There is not enough data for FRTX-03 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for FRTX-03 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 07 2024 23:55:13.

After 38 days of this quarter the interest is at 137.0. Based on that we can calculate that during remaining 53 days it will total up to 328.0.
skin conditions treatment expected interest is significantly lower compared to previous quarter (-51.6%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2019171
461
169.6% QoQ
249
-46.0% QoQ
263
5.6% QoQ
2020 331
93.6% YoY 25.9% QoQ
338
-26.7% YoY 2.1% QoQ
269
8.0% YoY -20.4% QoQ
404
53.6% YoY 50.2% QoQ
2021 341
3.0% YoY -15.6% QoQ
346
2.4% YoY 1.5% QoQ
228
-15.2% YoY -34.1% QoQ
391
-3.2% YoY 71.5% QoQ
2022 359
5.3% YoY -8.2% QoQ
352
1.7% YoY -1.9% QoQ
519
127.6% YoY 47.4% QoQ
454
16.1% YoY -12.5% QoQ
2023 445
24.0% YoY -2.0% QoQ
443
25.9% YoY -0.4% QoQ
453
-12.7% YoY 2.3% QoQ
677
49.1% YoY 49.4% QoQ
2024 137
-69.2% YoY -79.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and skin conditions treatment search interestLast update: February 07 2024 23:55:13.
Correlation coefficient between keyword and revenue is 0.02
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 07 2024 23:55:13.

The average 5 years interest of skin conditions treatment was 29.35 per week.
The last year interest of skin conditions treatment compared to the last 5 years has changed by 27.84%.
The interest for skin conditions treatment is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 51.35%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for next-generation kinase inhibitors to provide analysis

Correlation between past revenue and next-generation kinase inhibitors search interest

There is not enough data for next-generation kinase inhibitors to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for next-generation kinase inhibitors to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 07 2024 23:55:16.

After 38 days of this quarter the interest is at 38.0. Based on that we can calculate that during remaining 53 days it will total up to 91.0.
Brickell Biotech expected interest is significantly higher compared to previous quarter (+810.0%) and same quarter last year (+75.0%).

YearQ1Q2Q3Q4
201945
126
180.0% QoQ
225
78.6% QoQ
126
-44.0% QoQ
2020 162
260.0% YoY 28.6% QoQ
154
22.2% YoY -4.9% QoQ
163
-27.6% YoY 5.8% QoQ
150
19.0% YoY -8.0% QoQ
2021 349
115.4% YoY 132.7% QoQ
128
-16.9% YoY -63.3% QoQ
183
12.3% YoY 43.0% QoQ
99
-34.0% YoY -45.9% QoQ
2022 190
-45.6% YoY 91.9% QoQ
212
65.6% YoY 11.6% QoQ
106
-42.1% YoY -50.0% QoQ
116
17.2% YoY 9.4% QoQ
2023 52
-72.6% YoY -55.2% QoQ
57
-73.1% YoY 9.6% QoQ
54
-49.1% YoY -5.3% QoQ
10
-91.4% YoY -81.5% QoQ
2024 38
-26.9% YoY 280.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Brickell Biotech search interestLast update: February 07 2024 23:55:16.
Correlation coefficient between keyword and revenue is 0.82
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 07 2024 23:55:17.

The average 5 years interest of Brickell Biotech was 10.56 per week.
The last year interest of Brickell Biotech compared to the last 5 years has changed by -64.68%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -65.24%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for FRTX
Earnings date: 2024-03-28 After close
Company name: Fresh Tracks Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2024-06-11T21:37:53-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

2024-05-31T17:29:19-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

2024-05-23T17:29:14-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

2024-05-20T17:40:40-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

2024-05-08T16:10:47-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

2024-05-08T16:01:47-04:00

SEC
SC 13D Form - General statement of acquisition of beneficial ownership - Fresh Tracks Therapeutics, Inc. (0000819050) (Subject)

2024-05-03T17:24:13-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

2024-04-23T17:10:20-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

2024-04-11T17:12:39-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

2024-04-05T17:18:51-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

2024-04-01T17:21:53-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

2024-03-21T17:14:03-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)

2024-03-18T17:05:32-04:00

SEC
15-12G Form - Securities registration termination [Section 12(g)] - Fresh Tracks Therapeutics, Inc. (0000819050) (Filer)

2024-03-15T16:09:01-04:00

SEC
10-K Form - Annual report [Section 13 and 15(d), not S-K Item 405] - Fresh Tracks Therapeutics, Inc. (0000819050) (Filer)

2024-03-13T17:23:12-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)